Susceptibility of ampicillin-resistant Haemophilus influenzae to seven penicillins

Insights

Most clinical Haemophilus influenzae isolates resistant to ampicillin produce beta-lactamase. Ticarcillin and carbenicillin showed the greatest activity against these bacteria, though clinical utility remains unproven.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Haemophilus influenzae is a significant human pathogen.
  • Antibiotic resistance, particularly to ampicillin, is a growing concern.
  • Beta-lactamase production is a common mechanism of resistance.

Purpose of the Study:

  • To evaluate the susceptibility of clinical Haemophilus influenzae isolates to various penicillins.
  • To determine the prevalence of beta-lactamase production in ampicillin-resistant strains.
  • To compare the in vitro activity of different beta-lactam antibiotics.

Main Methods:

  • Testing 67 clinical isolates of Haemophilus influenzae from the US, UK, and Germany.
  • Assessing susceptibility to penicillin, ampicillin, amoxicillin, epicillin, carbenicillin, ticarcillin, and methicillin.
  • Detecting beta-lactamase production in ampicillin-resistant and susceptible strains.
  • Determining minimal inhibitory concentrations (MICs) for comparative analysis.

Main Results:

  • 53 of 67 isolates were ampicillin-resistant; 14 were ampicillin-susceptible.
  • Beta-lactamase was produced by 52 of the 53 ampicillin-resistant strains.
  • None of the ampicillin-susceptible strains produced beta-lactamase.
  • Ticarcillin and carbenicillin demonstrated the highest activity based on MICs.

Conclusions:

  • Beta-lactamase production is strongly associated with ampicillin resistance in clinical Haemophilus influenzae isolates.
  • Ticarcillin and carbenicillin exhibit potent in vitro activity against these strains.
  • Further clinical studies are needed to establish the therapeutic value of ticarcillin and carbenicillin.

Related Concept Videos

Bacterial Cell Wall01:22

Bacterial Cell Wall

The bacterial cell wall is an essential structural component that encases the plasma membrane, preserving cellular integrity, determining shape, and protecting against osmotic stress. This rigid yet flexible structure primarily comprises peptidoglycan, a polymer that forms a mesh-like matrix conferring mechanical strength and flexibility.Peptidoglycan Composition and StructurePeptidoglycan, the core of the bacterial cell wall, comprises alternating units of N-acetylglucosamine (NAG) and...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...